Pacira | PCRX - 営業経費





営業経費 変化する 日付
Astellas Pharma JPY 455.56B 33.8B 2026-06
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
Cara Therapeutics USD 7.05M 1.11M 2026-03
Coherus Biosciences USD 51.83M 2.48M 2025-12
Heron Therapeutics USD 40.55M 1.46M 2025-12
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
J&J USD 18.93B 1.09B 2026-09
Ligand Pharmaceuticals USD 94.5M 39.4M 2026-09
Nektar Therapeutics USD 49.12M 8.22M 2026-03
Novo Nordisk DKK 44.73B 7.52B 2026-06
Omeros USD 59.16M 20.13M 2024-06
Pacira USD 180.54M 7.79M 2026-06
Perrigo USD 290.5M 645.1M 2026-06
Pfizer USD 89B 3.81B 2026-09
Supernus Pharmaceuticals USD 1.06B 31.25M 2026-09
Teva Pharmaceutical Industries USD 3.92B 691M 2026-06
Xeris Pharmaceuticals USD 86.93M 11.72M 2026-06
Zoetis USD 3.15B 85M 2026-06